The Global Diabetes Pen Market to witness growing demand for Diabetes Pen, which is primarily attributed to the factors such as the increasing prevalence of lifestyle disorders, such as diabetes and obesity, increasing awareness regarding the ease-of-use of diabetes pens, the improvement in patient adherence and compliance to the treatment regimen, and technologically advanced products such as smart insulin pens, are expected to drive the Diabetes Pen Market.
According to the latest report published by DelveInsight Diabetes Pen Market Insight, Competitive Landscape & Market Forecast 2027, the global Diabetes Pen Market is expected to witness appreciable growth in product demand owing to various reasons, one of the major factors influencing the growth of the Diabetes Pen Market is the advantages offered by diabetes pens over conventional syringe and vials mode of insulin administration is further expected to boost the market growth. Also, the Diabetes Pens market is witnessing growth due to the rising requirement for these devices to cater to the large diabetic patient population globally.
Interested in knowing how the Diabetes Pen Market is expected to grow by 2027? Click to get a snapshot of the Diabetes Pen Market Sample Report
Diabetes Pen Overview
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin, a hormone that regulates blood sugar, or when the body cannot effectively use the insulin it produces. It can be classified into three main types, namely, Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. Among all the most common is type 2, usually affecting adults as a result when the body becomes resistant to insulin or produces insufficient insulin.
The Diabetes Pen ensures insulin delivery in the patient’s body in patients suffering from diabetes. The pen comprises a cartridge that carries insulin hormone, a dial to measure the insulin dosage, and disposable pen needles that are injected to deliver insulin into the body.
Diabetes Pen Market Insight
Among all the regions, APAC is expected to witness the fastest growth in the revenue in the diabetes pens market during the forecast period. The reasons for this fast growth can be correlated to the large patient population in the region, rising disposable income, and increasing focus of the market players in improving their market access in the APAC region. APAC is predicted to register the fastest growth in the diabetes pens market because of an awareness of diabetes and its management, and improving disposable income, among other factors in the region.
According to DelveInisght estimates, in the product segment of the Diabetes Pen market, the reusable Diabetes Pen category is expected to account for the larger market share during the forecast period. Reusable Diabetes Pens offer advantages such as greater flexibility in terms of reusing the same pen if a prescription for the insulin type changes.
In May 2022, Eli Lilly entered into agreements with four companies DexCom, Inc., Glooko Inc., myDiabby Healthcare and Roche – to advance connected solutions and streamline care for diabetic patients living outside of the United States. These companies offer unique diabetes management platforms which will be compatible with Lilly’s Tempo Pen™ (approved in several global markets) and Tempo Smart Button™ (currently in late-stage development).
Recent Developments in the Diabetes Pen Market report–
- In May 2022, Medtronic plc received the CE (Conformité Européenne) Mark approval for their InPen smart insulin pen for expanded functionality as multiple daily injections (MDI).
- In May 2022, Eli Lilly entered into agreements with four companies DexCom, Inc., Glooko Inc., myDiabby Healthcare, and Roche – to advance connected solutions and streamline care for diabetic patients living outside of the United States. These companies offer unique diabetes management platforms which will be compatible with Lilly’s Tempo Pen™ (approved in several global markets) and Tempo Smart Button™ (currently in late-stage development).
- In May 2022, Bigfoot Medical received 510k approval from the US Food and Drug Administration for their first-of-its-kind Bigfoot Unity™ Diabetes Management System. It features connected smartpen caps that recommend insulin doses for people using multiple daily injection (MDI) therapy.
Want to understand better why the APAC region is captivating the major Diabetes Pen Market share? Click to get a snapshot of Diabetes Pen Market Analysis
Key Players in the Diabetes Pen Market
Some of the key market players operating in the diabetes pens market includes BD, Medtronic, Terumo Group, F Hoffmann-La Roche Ltd., BIGFOOT BIOMEDICAL, INC, Eli Lilly and Company, Novo Nordisk A/S, Emperra GmbH E-Health Technologies, Copernicus (Nemera), ARKRAY USA, Inc., Ypsomed AG, HTL-Strefa (MTD Medical Technology and Devices S.A), Trividia Health, Inc, Sanofi, and others.
Diabetes Pen Market Dynamics
One of the key factors supporting the growth of the Diabetes Pen market in the region is the high prevalence of diabetes that will lead to a greater demand for Diabetes Pen in the market, further elevating the market growth. There are great opportunities for Diabetes Pen market penetration for the countries like the United States, the UK, and Italy as the prevalence rate is high in these countries also. Moreover, considering the long-term benefit, the reusable Diabetes Pen appears to be more economical compared to conventional Diabetes Pens. Hence, the launch of new innovative products will lead to an increased demand for reusable Diabetes Pen, further leading to an increase in the Diabetes Pen market growth.
The demand for Diabetes Pen is primarily affected by the outbreak of the COVID-19 pandemic because of the delay in the supply and manufacturing of the products.
To better understand the short/long-term impact of COVID-19 on the Diabetes Pen Market. Get a snapshot @ Diabetes Pen Market Impact Due to COVID-19
Scope of the Diabetes Pen Market Report
- Coverage: Global
- Study Period: 2019-2027
- Market Segmentation By Product Type: Disposable And Reusable [Conventional And Smart]
- Market Segmentation By Application: Type 1 Diabetes, Type 2 Diabetes, And Gestational Diabetes
- Market Segmentation By End-User: Hospitals & Clinics, Homecare Settings, And Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Diabetes Pen Companies – BD, Medtronic, Terumo Group, F Hoffmann-La Roche Ltd., BIGFOOT BIOMEDICAL, INC, Eli Lilly and Company, Novo Nordisk A/S, Emperra GmbH E-Health Technologies, Copernicus (Nemera), ARKRAY USA, Inc., Ypsomed AG, HTL-Strefa (MTD Medical Technology and Devices S.A), Trividia Health, Inc, Sanofi and others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Delveinsight Analysis: As per DelveInsight estimates, the Global Diabetes Pens Market was valued at USD 24.01 billion in 2022, growing at a CAGR of 4.70% during the forecast period from 2022 to 2027 to reach USD 31.56 billion by 2027.
Know more about which key player is set to dominate the Diabetes Pen Market @ Key Diabetes Pen Companies
Table of Contents
| 1 | Diabetes Pen Market Report Introduction |
| 2 | Diabetes Pen Market Executive Summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Diabetes Pen Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Diabetes Pen Market |
| 7 | Diabetes Pen Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Diabetes Pen Market Key Companies and Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Know more about Diabetes Pen @ Diabetes Pen Market Report Sample
Related Reports
DelveInsight’s, “Diabetes Pipeline Insights, 2022,” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical, non-clinical stage products and key companies involved such as Janssen Biotech, Zealand Pharma, Provention Bio, BioRestorative Therapies, Elevian, Kamada, Adocia, Oramed Pharmaceuticals, ImCyse, Histogen, Novo Nordisk, Enthera, and many more.
Intranasal Drug Delivery Market
The Global Intranasal Drug Delivery Market report delivers an in-depth understanding and the historical and forecasted market trends, market drivers, market barriers, and key companies like AFT Pharmaceuticals, AptarGroup, Inc., SaNOtize Research & Development Corp., Becton, Dickinson and Company, Oyster Point Pharma, Inc., Impel Neuropharma, Teleflex Incorporated, SipNose, Kurve Technology, Inc, Mystic Pharmaceuticals, Medica Holdings, LLC, 3M Company, Neurelis, Inc., PENDOPHARM, GlaxoSmithKline. Cipla, Glenmark Pharmaceuticals, Novartis AG, AstraZeneca, Johnson & Johnson and others.
Chronic Pain associated with Painful Diabetic Neuropathy Market
DelveInsight’s ‘Chronic Pain associated with Painful Diabetic Neuropathy- Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Chronic Pain associated with Painful Diabetic Neuropathy covering the market trends, market drivers, market barriers and key companies involved such as Janssen Pharmaceuticals, Grunethal, Pfizer, Eli Lilly, Shionogi, Ono pharmaceuticals, Fremslife S.r.l, Helixmith, Aptinyx, Regenacy Pharmaceuticals, Novaremed, Nevro Corp, Erchonia Corporation, and others.
“DelveInsight’s ‘Drug-Eluting Stents – Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Drug-Eluting Stents and the historical and forecasted Drug-Eluting Stents market trends, market drivers, market barriers and key companies like Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, STENTYS SA, Lepu Medical, Cook, Cardinal Health, and others.
Injectable Drug Delivery Devices Market
Global Injectable Drug Delivery Devices Market report delivers in-depth understanding and the historical and forecasted market trends, market drivers, market barriers and key companies like Eli Lilly and Company, Biocon, Becton, Dickinson & Company, West Pharmaceutical Services, Johnson & Johnson, Antares Pharma, AbbVie Inc, Pfizer Inc., Mylan N.V., Vetter Pharma-Fertigung GmbH & Co.KG, and others.
Transdermal Drug Delivery Devices Market
Transdermal Drug Delivery Devices Market report delivers in-depth understanding and the historical and forecasted market trends, market drivers, market barriers and key companies like Hisamitsu Pharmaceutical, Mylan, UCB SA, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, Purdue Pharma, Bristol-Myers Squibb Company, Endo Pharmaceuticals Inc., Acrux Limited, Lavipharm, Lead Chemicals Co. Inc., Luye Pharma Group, and others.
Injectable Drug Delivery Devices Market
Global Injectable Drug Delivery Devices Market report delivers an in-depth understanding of Injectable Drug Delivery Devices and the historical and forecasted market trends, market drivers, market barriers and key companies involved such as Eli Lilly and Company, Biocon, Becton, Dickinson & Company, West Pharmaceutical Services, Johnson & Johnson, Antares Pharma, AbbVie Inc, Pfizer Inc, Mylan N.V. and others.
DelveInsight’s ‘Smart Insulin Pens Market Insights, Competitive Landscape and Market Forecast-2027’ report delivers an in-depth understanding of Smart Insulin Pens and the historical and forecasted Smart Insulin Pens market trends, market drivers, market barriers and key companies involved such as Novo Nordisk, DiabNext, InsulCloud, Medtronic, Companion Medical, Biocorp, Bigfoot Medical, Emperra GmbH E-Health Technologies, and others.
Insulin Delivery Devices Market
Insulin Delivery Devices Market is anticipated to expand at a significant CAGR forecast till 2027 due to rising prevalence of diabetes across the globe. The report delivers an in-depth understanding of Insulin Delivery Devices and the historical and forecastedInsulin Delivery Devices market trends, market drivers, market barriers and key companies involved such as Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo, CeQur, EOFLOW CO., LTD, European Pharma Group BV, Roche, Sanofi, Hindustan Syringes & Medical Devices Ltd, Ocean (Hangzhou) Medical Technology Co Ltd, Owen Mumford, and others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187